Monoclonal antibodies to the human LDL receptor, their production and use
US6849720B2 · kind B2 · utility
1Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2001 |
| Grant date | Feb 1, 2005 |
| Priority date | — |
| Expiry date | Mar 8, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are provided monoclonal antibodies to the LDL receptor which are useful for the identification and purification of LDL and in treatment of e.g. hepatitis C infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.